Tell the FDA and the UN that CBD is Beneficial Today!

cbd cannabidiol

Holy smokes!

Apologize for the short notice, but I just learned that the United States Food and Drug Administration (FDA) is taking comments for recommendations on wording it plans to give in the near future to the World Health Organization (WHO). Today is the deadline, so make your comment today. CLICK HERE TO SUBMIT A COMMENT.

The comments will be reviewed in advance of a report regarding a number of controlled substances which WHO will be issuing for the United Nations Secretary-General later this fall. One of those substances is cannabidiol (CBD), one of the most actively therapeutic components of cannabis.

From the FDA’s Regulations.Gov website:

“The United States is a party to the 1971 Convention on Psychotropic Substances (Psychotropic Convention). Article 2 of the Psychotropic Convention provides that if a party to the convention or WHO has information about a substance, which in its opinion may require international control or change in such control, it shall so notify the Secretary-General of the United Nations (the U.N. Secretary-General) and provide the U.N. Secretary-General with information in support of its opinion.

“Section 201 of the CSA (21 U.S.C. 811) (Title II of the Comprehensive Drug Abuse Prevention and Control Act of 1970) provides that when WHO notifies the United States under Article 2 of the Psychotropic Convention that it has information that may justify adding a drug or other substances to one of the schedules of the Psychotropic Convention, transferring a drug or substance from one schedule to another, or deleting it from the schedules, the Secretary of State must transmit the notice to the Secretary of Health and Human Services (Secretary of HHS). The Secretary of HHS must then publish the notice in the Federal Register and provide opportunity for interested persons to submit comments that will be considered by HHS in its preparation of the scientific and medical evaluations of the drug or substance.”

We need to act fast, but there’s still time to make our voices heard: THE DEADLINE TO SUBMIT COMMENTS IS WEDNESDAY, SEPTEMBER 13TH! This is a great and easy form of activism, and I would encourage all of our readers and supporters to send a quick comment to let the FDA know that you recognize, along with thousands of scientific studies, CBD is a medically therapeutic substance. CLICK HERE TO SUBMIT A COMMENT TODAY.

National and international laws should catch up to science and reflect the reality that most US (and other) citizens recognize: cannabis is a safe and effective medicine!

Keep up with the latest happenings in global cannabis policy at the International Cannabis Business Conference! Our next event is happening December 1-3, 2017 in Kauai, Hawaii! Get your early bird tickets today!

This blog, although updated, was originally published at Marijuana Politics, and has been posted here with special permission.
Amber Iris Langston
About Amber Iris Langston 24 Articles
Amber Iris Langston has been an outspoken advocate for cannabis and drug policy reform for nearly 20 years. Ms. Langston is a founder and deputy director of Show-Me Cannabis, co-author of New Approach Missouri’s successful Amendment 2 medical initiative that just passed in 2018, and was the campaign manager for Columbia, Missouri’s two successful municipal cannabis initiatives in 2004. Amber has served as an outreach director and international liaison for Students for Sensible Drug Policy in Washington, DC, as field support for Americans for Safe Access in Oakland, CA, and as media liaison for California’s Proposition 19 to tax and regulate cannabis in 2010. Amber currently lives in Portland, Oregon, where she works with the medical and legal cannabis community, and continues her social justice and environmental advocacy.